Hemorrhage
278
22
27
176
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
47 trials with published results (17%)
Research Maturity
176 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.8%
16 terminated out of 278 trials
91.7%
+5.1% vs benchmark
24%
68 trials in Phase 3/4
27%
47 of 176 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 176 completed trials
Clinical Trials (278)
Onyx™ Liquid Embolic IDE Clinical Study
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
Okami Medical ALPHA Registry
Effectiveness of the Pressure Recording Analytical Method in Predicting Fluid Responsiveness in Pediatric Critical Care Patients
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
Platelets and Extracorporeal Membrane Oxygenation Veno-venous
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils
Cone Beam Computed Tomography Following Thrombectomy
REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Obsidio™ Conformable Embolic Registry
CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.
SWIFT - SWIss Factor XIII Trial in PPH
U-CaVIT Versus Standard of Care for Prevention of Atonic Postpartum Hemorrhage After Cesarean Section in High-risk Women.